Clinical trials sponsored by Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Suzhou Suncadia Biopharmaceuticals Co., Ltd.

• A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
  NCT07111832 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• A Multicenter, Open-label Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-6914 Injection in Participants With Prostate Cancer
  NCT07735377 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
  NCT06754930 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
  NCT07183189 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Phase III Study of SHR-8068 Combined With Adebrelimab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer
  NCT07170995 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Suzhou Suncadia Biopharmaceuticals Co., Ltd. recruiting for?

Suzhou Suncadia Biopharmaceuticals Co., Ltd. is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.